T cell responses against tumor associated antigens and prognosis in colorectal cancer patients

Por Nagorsen, Dirk, Scheibenbogen, Carmen, Letsch, Anne, Germer, Christoph-Thomas, Buhr, Heinz-Johannes, Hegewisch-Becker, Susanna, Rivoltini, Licia, Thiel, Eckhard, Keilholz, Ulrich
Publicado em 2005

Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ducta...

Por Hegewisch‐Becker, Susanna, Aldaoud, Ali, Wolf, Thomas, Krammer‐Steiner, Beate, Linde, Hartmut, Scheiner‐Sparna, Renate, Hamm, David, Jänicke, Martina, Marschner, Norbert
Publicado no Int J Cancer (2018)

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial

Por Stein, Alexander, Kretzschmar, Albrecht, Behringer, Dirk, Wolff, Thomas, Zimber, Joachim, Hegewisch-Becker, Susanna, Kettner, Erika, Pflüger, Karl-Heinz, Kirsch, Andreas, Arnold, Dirk
Publicado em 2013

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of...

Por Stintzing, Sebastian, Ivanova, Boryana, Ricard, Ingrid, Jung, Andreas, Kirchner, Thomas, Tannapfel, Andrea, Juette, Hendrik, Hegewisch-Becker, Susanna, Arnold, Dirk, Reinacher-Schick, Anke
Publicado no Front Oncol (2018)

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Por Al‐Batran, Salah‐Eddin, Moorahrend, Enno, Maintz, Christoph, Goetze, Thorsten O., Hempel, Dirk, Thuss‐Patience, Peter, Gaillard, Vincent E., Hegewisch‐Becker, Susanna
Publicado no Oncologist (2020)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an indi...

Por Goey, Kaitlyn K H, Elias, Sjoerd G, Hinke, Axel, van Oijen, Martijn G H, Punt, Cornelis J A, Hegewisch-Becker, Susanna, Arnold, Dirk, Koopman, Miriam
Publicado no Br J Cancer (2017)

ABC1 Consensus Conference – a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011

Por Thomssen, Christoph, Marschner, Norbert, Untch, Michael, Decker, Thomas, Hegewisch-Becker, Susanna, Jackisch, Christian, Janni, Wolfgang, Hans-Joachim, Lück, von Minckwitz, Gunter, Scharl, Anton, Schneeweiss, Andreas, Tesch, Hans, Welt, Anja, Harbeck, Nadia
Publicado em 2012

Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer

Por Marschner, Norbert, Zacharias, Stefan, Lordick, Florian, Hegewisch-Becker, Susanna, Martens, Uwe, Welt, Anja, Hagen, Volker, Gleiber, Wolfgang, Bohnet, Sabine, Kruggel, Lisa, Dille, Stephanie, Nusch, Arnd, Dörfel, Steffen, Decker, Thomas, Jänicke, Martina
Publicado no JAMA Netw Open (2020)

Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective

Por Harbeck, Nadia, Marschner, Norbert, Untch, Michael, Decker, Thomas, Hegewisch-Becker, Susanna, Jackisch, Christian, Huober, Jens, Lück, Hans-Joachim, von Minckwitz, Gunter, Scharl, Anton, Schneeweiss, Andreas, Tesch, Hans, Welt, Anja, Wuerstlein, Rachel, Thomssen, Christoph
Publicado em 2014

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of...

Por Luber, Birgit, Deplazes, Joëlle, Keller, Gisela, Walch, Axel, Rauser, Sandra, Eichmann, Martin, Langer, Rupert, Höfler, Heinz, Hegewisch-Becker, Susanna, Folprecht, Gunnar, Wöll, Ewald, Decker, Thomas, Endlicher, Esther, Lorenzen, Sylvie, Fend, Falko, Peschel, Christian, Lordick, Florian
Publicado em 2011

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INT...

Por Tintelnot, Joseph, Goekkurt, Eray, Binder, Mascha, Thuss-Patience, Peter, Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Kretzschmar, Albrecht, Ettrich, Thomas, Lindig, Udo, Jacobasch, Lutz, Pink, Daniel, Al-Batran, Salah-Eddin, Hinke, Axel, Hegewisch-Becker, Susanna, Nilsson, Sven, Bokemeyer, Carsten, Stein, Alexander
Publicado no BMC Cancer (2020)

Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)

Por Schimanski, Carl Christoph, Kasper, Stefan, Hegewisch-Becker, Susanna, Schröder, Jan, Overkamp, Friedrich, Kullmann, Frank, Bechstein, Wolf Otto, Vöhringer, Matthias, Öllinger, Robert, Lordick, Florian, Heinemann, Volker, Geißler, Michael, Schulz-Abelius, Armin, Bernhard, Helga, Schön, Michael R., Greil, Richard, Galle, Peter, Lang, Hauke, Schmidtmann, Irene, Moehler, Markus
Publicado no Oncoimmunology (2020)

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3...

Por Heinemann, Volker, Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C, von Weikersthal, Ludwig Fischer, Clemens, Michael R, Geissler, Michael, Greten, Tim F, Hegewisch-Becker, Susanna, Rubanov, Oleg, Baake, Gerold, Höhler, Thomas, Ko, Yon D, Jung, Andreas, Neugebauer, Sascha, Boeck, Stefan
Publicado no Gut (2012)

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded pha...

Por Schimanski, Carl Christoph, Möhler, Markus, Schön, Michael, van Cutsem, Eric, Greil, Richard, Bechstein, Wolf Otto, Hegewisch-Becker, Susanna, von Wichert, Götz, Vöhringer, Matthias, Heike, Michael, Heinemann, Volker, Peeters, Marc, Kanzler, Stephan, Kasper, Stefan, Overkamp, Friedrich, Schröder, Jan, Seehofer, Daniel, Kullmann, Frank, Linz, Bernhard, Schmidtmann, Irene, Smith-Machnow, Victoria, Gockel, Ines, Lang, Hauke, Galle, Peter R
Publicado em 2012

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO...

Por Moehler, Markus, Gepfner-Tuma, Irina, Maderer, Annett, Thuss-Patience, Peter C., Ruessel, Joern, Hegewisch-Becker, Susanna, Wilke, Hansjochen, Al-Batran, Salah-Eddin, Rafiyan, Mohammad-Reza, Weißinger, Florian, Schmoll, Hans-Joachim, Kullmann, Frank, von Weikersthal, Ludwig Fischer, Siveke, Jens T., Weusmann, Jens, Kanzler, Stephan, Schimanski, Carl Christoph, Otte, Melanie, Schollenberger, Lukas, Koenig, Jochem, Galle, Peter R.
Publicado no BMC Cancer (2016)